-
公开(公告)号:US11801274B2
公开(公告)日:2023-10-31
申请号:US17885189
申请日:2022-08-10
发明人: Hsieh-Hsun Ho , Yi-Wei Kuo , Yen-Yu Huang , Jia-Hung Lin , Ko-Chiang Hsia , Ching-Wei Chen , Shin-Yu Tsai
IPC分类号: A61K35/745 , A61P29/00 , A23L33/135
CPC分类号: A61K35/745 , A23L33/135 , A61P29/00
摘要: Disclosed herein is a method for alleviating atopic dermatitis using a composition containing at least one lactic acid bacterial strain. The at least one lactic acid bacterial strain is selected from the group consisting of Lactobacillus salivarius subsp. salicinius AP-32 which is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, and Bifidobacterium animalis subsp. lactis CP-9 which is deposited at the CCTCC under an accession number CCTCC M 2014588.
-
公开(公告)号:US11730779B2
公开(公告)日:2023-08-22
申请号:US17669752
申请日:2022-02-11
发明人: Hsieh-Hsun Ho , Yi-Wei Kuo , Jia-Hung Lin , Hui-Shan Wang , Yen-Yu Huang , Wen-Yang Lin , Ko-Chiang Hsia
IPC分类号: A61K35/747 , A61P3/00 , A61K35/745 , A61N5/06 , A61K35/00 , A61P31/04
CPC分类号: A61K35/747 , A61K35/745 , A61N5/0621 , A61P3/00 , A61P31/04 , A61K2035/115
摘要: The present invention provides a lactic acid bacterial composition for inhibiting the activity of Escherichia coli and/or treating or preventing jaundice, the composition including: a Bifidobacterium animalis subsp. lactis CP-9 strain and a Lactobacillus salivarius subsp. salicinius AP-32 strain. The present invention further provides a method for inhibiting growth of Escherichia coli, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.
-